Scientists discover migrions that accelerate viral infections

Researchers have identified migrions, virus-like structures that enable faster and more severe viral spread by hijacking cell movement. These packages, formed in migrating cells infected with vesicular stomatitis virus, deliver multiple viral genomes simultaneously to new cells. The discovery challenges traditional models of infection and highlights increased disease potential in animal tests.

A team from Peking University Health Science Center and the Harbin Veterinary Research Institute has revealed a novel mechanism of viral transmission detailed in a study published in Science Bulletin. The research focuses on vesicular stomatitis virus (VSV), where infected cells pack viral genetic material and proteins into migrasomes—cellular structures that emerge during cell migration.

These migrasomes, containing viral nucleic acids and displaying the VSV surface protein VSV-G, form large virus-like entities dubbed "migrions." Unlike individual virus particles, migrions combine viral and cellular components, allowing for collective delivery. This bundling enables quicker replication in recipient cells, as multiple viral genomes arrive at once, initiating parallel infection processes.

Migrions stand out for their ability to transport more than one virus type simultaneously, differing from standard extracellular vesicle transmission. Upon reaching a new cell, they enter via endocytosis. Acidic conditions inside then activate VSV-G, prompting fusion with endosomes and release of viral contents to kickstart replication.

In mouse experiments, migrion-mediated infections proved far more potent than free virus exposure. Affected animals suffered severe lung and brain conditions, including encephalitis, often leading to fatal outcomes. This underscores the heightened pathogenicity of the migration-linked route.

The researchers describe migrions as a chimeric structure bridging viruses and migrasomes, introducing a migration-dependent transmission model. By exploiting the body's migratory systems, viruses can propagate more efficiently and systemically, potentially explaining rapid escalations in certain infections.

Articoli correlati

Illustration of a mouse intestine cross-section comparing exosomes in young and old mice for aging research news.
Immagine generata dall'IA

Study links gut “luminal exosomes” to age-related inflammation and metabolic decline in mice

Riportato dall'IA Immagine generata dall'IA Verificato

Researchers at Marshall University report that microscopic particles found in the gut lumen—known as exosomes—differ between young and old mice and can influence metabolism and gut-barrier function when transferred between animals. The findings, published in the journal Aging Cell, suggest these particles may help drive biological changes associated with aging, though the work is preclinical.

La Trobe University researchers say dying cells can leave behind a residue containing newly identified extracellular vesicles that help direct immune clearance, but laboratory experiments suggest influenza viruses may also use the vesicles to help spread.

Riportato dall'IA

Researchers found that infecting mice with respiratory syncytial virus (RSV) reduced breast cancer cells' ability to form tumors in the lungs by 65 to 70 percent. The effect stems from type I interferons, proteins that fight viral replication and hinder cancer cell seeding. The study raises hopes for drugs mimicking this mechanism.

Researchers at Fred Hutch Cancer Center have created human-like monoclonal antibodies that prevent Epstein-Barr virus (EBV) from infecting immune cells. Using mice engineered with human antibody genes, the team identified antibodies targeting viral proteins gp350 and gp42, with one fully blocking infection in lab models. The findings, published in Cell Reports Medicine, could lead to therapies for transplant patients at risk of EBV-related complications.

Riportato dall'IA

Scientists at McMaster University and the Hospital for Sick Children in Canada have discovered that oligodendrocytes, cells typically supporting nerve function, aid the growth of glioblastoma by sending signals to tumor cells. Blocking this communication slowed tumor progression in lab models. The findings suggest an existing HIV drug, Maraviroc, could be repurposed for treatment.

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta